![Thomas Dayspring on Twitter: "Errors of underestimated calculated LDLc compared to measured LDLc increase at LDLC < 70 mg/dl: but reality is that most clinical trials demonstrating the benefit of LDLc-lowering have Thomas Dayspring on Twitter: "Errors of underestimated calculated LDLc compared to measured LDLc increase at LDLC < 70 mg/dl: but reality is that most clinical trials demonstrating the benefit of LDLc-lowering have](https://pbs.twimg.com/media/DonFyiqU0AEpmIY.jpg)
Thomas Dayspring on Twitter: "Errors of underestimated calculated LDLc compared to measured LDLc increase at LDLC < 70 mg/dl: but reality is that most clinical trials demonstrating the benefit of LDLc-lowering have
![Dr Deepak Krishnamurthy on Twitter: "Lp(a) is a lipoprotein consisting of an LDL molecule with another protein (Apolipoprotein (a)) attached to it. Lp(a) is similar to LDL-C but does not respond to Dr Deepak Krishnamurthy on Twitter: "Lp(a) is a lipoprotein consisting of an LDL molecule with another protein (Apolipoprotein (a)) attached to it. Lp(a) is similar to LDL-C but does not respond to](https://pbs.twimg.com/media/E7_waOoVkAUGfmC.jpg)
Dr Deepak Krishnamurthy on Twitter: "Lp(a) is a lipoprotein consisting of an LDL molecule with another protein (Apolipoprotein (a)) attached to it. Lp(a) is similar to LDL-C but does not respond to
![Cholesterol is Inefficiently Converted to Cholesteryl Esters in the Blood of Cardiovascular Disease Patients | Scientific Reports Cholesterol is Inefficiently Converted to Cholesteryl Esters in the Blood of Cardiovascular Disease Patients | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-018-33116-4/MediaObjects/41598_2018_33116_Fig1_HTML.png)
Cholesterol is Inefficiently Converted to Cholesteryl Esters in the Blood of Cardiovascular Disease Patients | Scientific Reports
![Frontiers | Comparison of Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement and Lipid-Lowering Therapy in the Patients With Coronary Artery Disease With Different Renal Functions Frontiers | Comparison of Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement and Lipid-Lowering Therapy in the Patients With Coronary Artery Disease With Different Renal Functions](https://www.frontiersin.org/files/Articles/859567/fcvm-09-859567-HTML/image_m/fcvm-09-859567-g001.jpg)
Frontiers | Comparison of Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement and Lipid-Lowering Therapy in the Patients With Coronary Artery Disease With Different Renal Functions
The impact of the cumulative burden of LDL-c and hs-CRP on cardiovascular risk: a prospective, population-based study | Aging
![Cholesterol Crystals in Hepatocyte Lipid Droplets Are Strongly Associated With Human Nonalcoholic Steatohepatitis - Ioannou - 2019 - Hepatology Communications - Wiley Online Library Cholesterol Crystals in Hepatocyte Lipid Droplets Are Strongly Associated With Human Nonalcoholic Steatohepatitis - Ioannou - 2019 - Hepatology Communications - Wiley Online Library](https://aasldpubs.onlinelibrary.wiley.com/cms/asset/b1d0a72d-ae74-4a07-8d18-17eec0c7514a/hep41348-fig-0006-m.jpg)
Cholesterol Crystals in Hepatocyte Lipid Droplets Are Strongly Associated With Human Nonalcoholic Steatohepatitis - Ioannou - 2019 - Hepatology Communications - Wiley Online Library
![Metabolites | Free Full-Text | Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target Metabolites | Free Full-Text | Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target](https://pub.mdpi-res.com/metabolites/metabolites-11-00690/article_deploy/html/images/metabolites-11-00690-g001.png?1634700054)
Metabolites | Free Full-Text | Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target
Simvastatin Efficiently Lowers Small LDL-IgG Immune Complex Levels: A Therapeutic Quality beyond the Lipid-Lowering Effect | PLOS ONE
![SOLVED: aphan Iceutical compatly wculd Iike Investigate Ihe relabionship belwveen Ilie a903 and LDL (low-dansit AC dan 03 raemMich projrem Iot 4 ngw cholestetol ruq Kldla even Tanuumti sekdcdnten Canshutia 957 ccallercc SOLVED: aphan Iceutical compatly wculd Iike Investigate Ihe relabionship belwveen Ilie a903 and LDL (low-dansit AC dan 03 raemMich projrem Iot 4 ngw cholestetol ruq Kldla even Tanuumti sekdcdnten Canshutia 957 ccallercc](https://cdn.numerade.com/ask_images/43d776f2e0e5471eb0226e5aa5a12ab9.jpg)
SOLVED: aphan Iceutical compatly wculd Iike Investigate Ihe relabionship belwveen Ilie a903 and LDL (low-dansit AC dan 03 raemMich projrem Iot 4 ngw cholestetol ruq Kldla even Tanuumti sekdcdnten Canshutia 957 ccallercc
![CTBP1‑AS2 inhibits proliferation and induces autophagy in ox‑LDL‑stimulated vascular smooth muscle cells by regulating miR‑195‑5p/ATG14 CTBP1‑AS2 inhibits proliferation and induces autophagy in ox‑LDL‑stimulated vascular smooth muscle cells by regulating miR‑195‑5p/ATG14](https://www.spandidos-publications.com/article_images/ijmm/46/2/IJMM-46-02-0839-g04.jpg)
CTBP1‑AS2 inhibits proliferation and induces autophagy in ox‑LDL‑stimulated vascular smooth muscle cells by regulating miR‑195‑5p/ATG14
Novel method for quantification of lipoprotein(a)-cholesterol: implications for improving accuracy of LDL-C measurements
![Diseases | Free Full-Text | CVD Risk Stratification in the PCSK9 Era: Is There a Role for LDL Subfractions? Diseases | Free Full-Text | CVD Risk Stratification in the PCSK9 Era: Is There a Role for LDL Subfractions?](https://pub.mdpi-res.com/diseases/diseases-06-00045/article_deploy/html/images/diseases-06-00045-g001.png?1570140318)
Diseases | Free Full-Text | CVD Risk Stratification in the PCSK9 Era: Is There a Role for LDL Subfractions?
![Endothelial HMGB1 Is a Critical Regulator of LDL Transcytosis via an SREBP2–SR-BI Axis | Arteriosclerosis, Thrombosis, and Vascular Biology Endothelial HMGB1 Is a Critical Regulator of LDL Transcytosis via an SREBP2–SR-BI Axis | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/78280d5a-c487-4ad7-8226-c98b312e5f90/atvbaha.120.314557.fig07.jpg)
Endothelial HMGB1 Is a Critical Regulator of LDL Transcytosis via an SREBP2–SR-BI Axis | Arteriosclerosis, Thrombosis, and Vascular Biology
![Genome-wide RNAi screen reveals ALK1 mediates LDL uptake and transcytosis in endothelial cells | Nature Communications Genome-wide RNAi screen reveals ALK1 mediates LDL uptake and transcytosis in endothelial cells | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fncomms13516/MediaObjects/41467_2016_Article_BFncomms13516_Fig1_HTML.jpg)
Genome-wide RNAi screen reveals ALK1 mediates LDL uptake and transcytosis in endothelial cells | Nature Communications
![Dose-response relationship between the LDL-C/HDL-C and the probability... | Download Scientific Diagram Dose-response relationship between the LDL-C/HDL-C and the probability... | Download Scientific Diagram](https://www.researchgate.net/publication/346526078/figure/fig1/AS:963894130520069@1606821677210/Dose-response-relationship-between-the-LDL-C-HDL-C-and-the-probability-of-all-cause_Q640.jpg)
Dose-response relationship between the LDL-C/HDL-C and the probability... | Download Scientific Diagram
Sustained Release Strategy Designed for Lixisenatide Delivery to Synchronously Treat Diabetes and Associated Complications | ACS Applied Materials & Interfaces
![Intracellular AIBP (Apolipoprotein A-I Binding Protein) Regulates Oxidized LDL (Low-Density Lipoprotein)-Induced Mitophagy in Macrophages | Arteriosclerosis, Thrombosis, and Vascular Biology Intracellular AIBP (Apolipoprotein A-I Binding Protein) Regulates Oxidized LDL (Low-Density Lipoprotein)-Induced Mitophagy in Macrophages | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/2825050e-28c9-4cd2-9e61-0558b289ab30/atvbaha.120.315485.fig07.jpg)
Intracellular AIBP (Apolipoprotein A-I Binding Protein) Regulates Oxidized LDL (Low-Density Lipoprotein)-Induced Mitophagy in Macrophages | Arteriosclerosis, Thrombosis, and Vascular Biology
![LDL Receptor Regulates the Reverse Transport of Macrophage-Derived Unesterified Cholesterol via Concerted Action of the HDL-LDL Axis | Circulation Research LDL Receptor Regulates the Reverse Transport of Macrophage-Derived Unesterified Cholesterol via Concerted Action of the HDL-LDL Axis | Circulation Research](https://www.ahajournals.org/cms/asset/646aa5c6-8a6c-41b2-9f42-f9b4c56a0b08/circresaha.119.316424.fig06.jpg)
LDL Receptor Regulates the Reverse Transport of Macrophage-Derived Unesterified Cholesterol via Concerted Action of the HDL-LDL Axis | Circulation Research
![Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients - ScienceDirect Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109721001911-fx1.jpg)
Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients - ScienceDirect
![Frontiers | Higher Genetically Predicted Triglycerides, LDL, and HDL Increase the Vitamin D Deficiency: A Mendelian Randomization Study Frontiers | Higher Genetically Predicted Triglycerides, LDL, and HDL Increase the Vitamin D Deficiency: A Mendelian Randomization Study](https://www.frontiersin.org/files/Articles/862942/fnut-09-862942-HTML/image_m/fnut-09-862942-g001.jpg)